A pilot study of a comparison between a patient scored numeric rating scale and clinician scored measures of spasticity in multiple sclerosis

NeuroRehabilitation

Volumn 24, Issue 4, 2009, Pages 333-340

  Anwar, Khalid ^a,b   Barnes, M P ^a  

^a TYNE AND WEAR NHS FOUNDATION TRUST   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Measures of spasticity; Multiple sclerosis; Spasticity

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUMERIC RATING SCALE; PILOT STUDY; RATING SCALE; RELIABILITY; SCORING SYSTEM; SPASTICITY; VALIDATION STUDY;

ADULT; AGED; DISABILITY EVALUATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 68649086665     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/NRE-2009-0487     Document Type: Article

References (14)

1. M.P. Barnes, R.M. Kent, J.K. Semlyen and K.M. McMullen, Spasticity in Multiple Sclerosis Neurorehabil, Neural Repair 17 (2003), 66-70.
2. J.M. Bland and D.G. Altman, Validating scales indexes, BMJ 324 (2002), 606-607
3. R.W. Bohannon and M.B. Smith, Interrater reliability of a modified Ashworth scale of muscle spasticity, Phys Ther 67 (1987), 206-207.
4. R. Boyd and L. Ada, Physiotherapy management of spasticity, in: Upper mOtor Neuron Syndrome and Spasticity, M. Barnes and G. Johnson, eds, Clinical management and neurophys-iology. Cambridge, UK: Cambridge University Press, 2001, pp. 96-121.
5. C. Collin and D. Wade, Assessing motor impairment after stroke: a pilot reliability study, J Neurology Neurosurg Psychiatry 53 (1990), 576-579.
6. C. Collin, P. Davies, I. Mutiboko and S. Ratcliffe, Randomised Controlled Trial of Cannabis Based Medicine in Spasticity caused by Multiple Sclerosis, Eur J Neurol 14(3) (2007), 290-296.
7. J.T. Farrar, J.P. Young, Jr., L. LaMoreaux et al., Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale, Pain 94 (2001), 149-158.
8. J. Greenhalgh, H. Ford, A.F. Long and K. Hurst, The MS Symptom and Impact Diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis, J Neurol Neurosurg Psychiatry 75 (2004), 577-582.
9. J.C. Hobart, A. Riazi, D.L. Lamping, R. Fitzpatrick and A.J. Thompson, Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome, Health Technol Assess 8(9) (2004).
10. A.D. Pandyan, M. Gregoric, M.P. Barnes, D.J. Burridge, H. Hermens and G.R. Johnson, Spasticity: Clinical perceptions, neurological, Measurement Disability and Rehabilitation 27(1/2) (2005), 2-6.
11. A.D. Pandyan, C.I.M. Price, M.P. Barnes and G.R. Johnson, A biomechanical investigation into the validity of the Modified Ashworth Scale as a measure of elbow spasticity, Clin Rehab 17 (2003), 290-294.
12. A.D. Pandyan, C.I.M. Price, R.H. Curless et al., A review of the properties and limitations of the Ashworth and Modified Ashworth Scales as measures of spasticity, Clin Rehab 13 (1993), 373-383.
13. D.T. Shakespeare, M. Boggild and C. Young, Anti-spasticity agents for multiple sclerosis (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
14. The Committee for Proprietary Medicinal Products (CPMP). EMEA Guideline: Guideline on clinical investigation of medicinal products intended for the treatment of neuropathic pain. CHMP/EWP/252/03. London, 18th November 2004.